![]() ![]() In terms of regions, North America is expected to be the leading region in the market during the forecast period, owing to a growing geriatric population, increasing demand for point-of-care diagnostics, and outbreaks of bacterial and viral diseases. Infectious diseases are estimated to account for the major share of the market during the forecast period on account of the increasing number of infectious diseases such as SARS-CoV-2, new multidrug-resistant TB, H1N1, and HIV strains. ![]() By Application Typeīased on the application type, the market is segmented as infectious diseases, blood screening, oncology, genetic tests, and others. The high use of reagents in molecular diagnostic testing, increasing demand for over-the-counter diagnostic tests, and growing adoption of these tests in non-medical facilities such as home self-testing are driving the segment's growth. The reagents & kits segment is expected to hold the major share of the market during the forecast period. Want to have a closer look at this market report? Click Hereīased on the product type, the market is segmented as reagents & kits, instruments, and others. Since molecular diagnostics is vital in early detection, prognostics, and other clinical trials, the global market for molecular diagnostics will grow with the growing incidence of cancer. By 2040, the global cancer cases count is expected to rise to 27.5 million new cases. According to the American Cancer Society (ACS), in 2023, ~1,958,310 new cancer cases are predicted in the United States.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |